Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.3, ss.213-219, 2015 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 3
- Basım Tarihi: 2015
- Doi Numarası: 10.4274/tjh.2013.0336
- Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
- Sayfa Sayıları: ss.213-219
- Anahtar Kelimeler: Positron emission tomography, Computed tomography, Bone marrow biopsy, Hodgkin's lymphoma, Non-Hodgkin's lymphoma, FDG-PET, WHOLE-BODY, DISEASE, F-18-FLUORODEOXYGLUCOSE, FLUORODEOXYGLUCOSE, F-18-FDG, CT
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi Adresli: Evet
Özet
Objective: Positron emission tomography and computed tomography (PET/CT) has become an important part of staging and treatment evaluation algorithms of lymphoma. We aimed to compare the results of PET/CT with bone marrow biopsy (BMB) with respect to bone marrow involvement (BMI) in patients with Hodgkin's lymphoma (HL) and aggressive non-Hodgkin's lymphoma (aNHL).